Bookmark

Add to MyYahoo RSS

Matulane, Procarbazine News

News on Matulane, Procarbazine (generic) continually updated from thousands of sources around the net.

Nov 8, 2013 | PR-inside.com

Just Released: "Sigma-Tau Pharmaceuticals, Inc. - Pharmaceuticals &...

Sigma-Tau Pharmaceuticals, Inc. is a research based biotechnology company that focuses on discovering and developing novel medicines to treat rare diseases.

Comment?

Related Topix: Carnitor, Levocarnitine (generic), Medicine, Oncaspar, Pegaspargase (generic), Abelcet, Amphotericin B Lipid Complex (generic), Malaria, Health, Gaithersburg, MD

Wed Aug 28, 2013

Drugs.com

Hodgkin Lymphoma Treatment Tied to Higher Risk of Stomach Cancer in Study

Hodgkin lymphoma is a cancer of the immune system and is one of the most common cancers among teens and young adults in the United States.

Comment?

Related Topix: Lymphoma, Health

Tue Jul 09, 2013

CiteULike

Hypersensitivity reactions to anticancer agents: data mining of the...

Journal of experimental & clinical cancer research : CR , Vol. 30, No. 1. , doi:10.1186/1756-9966-30-93 Previously, adverse event reports submitted to the US Food and Drug Administration database were reviewed to confirm platinum agent-associated hypersensitivity reactions.

Comment?

Related Topix: Food and Drug Administration, Taxotere, Docetaxel (generic), Medicine, Vumon, Teniposide (generic), Elspar, Asparaginase (generic)

Fri Jun 21, 2013

PR-inside.com

Sigma-Tau Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare -...

It product portfolio comprises prescription products and consumer products. Sigma-Tau's prescription products include Adagen , Matulane , Carnitor , Oncaspar , Depocyt and Abelcet .

Comment?

Related Topix: Medicine, Oncaspar, Pegaspargase (generic), Carnitor, Levocarnitine (generic), Abelcet, Amphotericin B Lipid Complex (generic), Malaria, Health, Gaithersburg, MD

Fri May 31, 2013

MediLexicon

Patients With Anaplastic Oligodendroglioma Identified Who May Benefit From Adjuvant PCV

A further report on the results of EORTC trial 26951 indicates that CpG island methylator phenotype status and O 6-methylguanine-DNA methyltransferase promoter methylation as assessed by MGMT-STP27 are the most informative for identifying grade III glioma patients who might benefit from the addition of procarbazine, CCNU and vincristine ... (more)

Comment?

Related Topix: Medicine, Health, Brain Cancer

•••
•••
•••
•••
•••
•••
•••